Australien - engelska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - modified release tablets,isoptin sr is indicated for the management of hypertension and angina pectoris.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: sodium alginate; powdered cellulose; purified water; magnesium stearate; hypromellose; purified talc; titanium dioxide; povidone; macrogol 400; macrogol 6000; quinoline yellow; indigo carmine; glycol/butylene glycol montanate - isoptin sr (verapamil hydrochloride) is indicated for the management of essential hypertension and angina pectoris.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

Australien - engelska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

Irland - engelska - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - prolonged-release tablet - 240 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - mild to moderate hypertension and coronary heart disease, i.e. prophylaxis of myocardial ischaemia, angina pectoris.

Malta - engelska - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - prolonged-release tablet - verapamil hydrochloride 240 mg - calcium channel blockers

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 80 milligram

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 40 milligram

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 120 milligram

USA - engelska - NLM (National Library of Medicine)

ranbaxy laboratories inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - tablet, coated - 120 mg - isoptin sr (verapamil hci) is indicated for the management of essential hypertension. verapamil hci is contraindicated in: 1. severe left ventricular dysfunction (see warnings) 2. hypotension (systolic pressure less than 90 mmhg) or cardiogenic shock 3. sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) 4. second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). 5. patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings). 6. patients with known hypersensitivity to verapamil hydrochloride.